
    
      The goal of this study was to demonstrate that use of this device in conjunction with
      cataract surgery did not result in a rate of sight-threatening adverse events, after 5 years
      of implantation that was higher than the rate of sight-threatening adverse events that
      occurred after cataract surgery alone, by more than a non-inferiority margin of 5%.
    
  